---
title: "The concept of innovative drugs has repeatedly strengthened, with Lummy and other stocks hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248327077.md"
description: "The innovative drug concept has recently strengthened repeatedly, with Lummy hitting a 20% limit up. Previously, JLPC and Konruns also hit the limit up, while Yahui Pharmaceutical rose over 15%. Guangshengtang, Guanhao Biological, Taloph, and BrightGene all rose over 5%"
datetime: "2025-07-14T02:11:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248327077.md)
  - [en](https://longbridge.com/en/news/248327077.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248327077.md)
generator: "portal-rs"
---

# The concept of innovative drugs has repeatedly strengthened, with Lummy and other stocks hitting the daily limit

The innovative drug concept has recently strengthened repeatedly, with Lummy hitting a 20% limit up. Previously, JLPC and Konruns also hit the limit up, Yahuang Pharmaceutical rose over 15%, and BrightGene, Guanhao Biological, Taloph, and others all rose over 5%

### Related Stocks

- [600513.CN](https://longbridge.com/en/quote/600513.CN.md)
- [603590.CN](https://longbridge.com/en/quote/603590.CN.md)
- [300006.CN](https://longbridge.com/en/quote/300006.CN.md)
- [600222.CN](https://longbridge.com/en/quote/600222.CN.md)
- [688166.CN](https://longbridge.com/en/quote/688166.CN.md)

## Related News & Research

- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [CANSINOBIO  Tetanus Vaccine New Drug Application Approved](https://longbridge.com/en/news/296498620.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**